About this medicine
- Approved name
- Tredaptive, Pelzont and Trevaclyn
- International non-proprietary name (INN) or common name
- laropiprant
- nicotinic acid
- Associated names
- Tredaptive
- Pelzont
- Trevaclyn
- Class
- cardiovascular
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/C/889/A20/37, EMEA/H/C/903/A20/38, EMEA/H/C/897/A20/38
- Type
- Article 20 procedures
This type of procedure is triggered for medicines that have been authorised via the centralised procedure in case of quality, safety or efficacy issues.
- Authorisation model
- Centrally authorised product(s)
- Decision making model
- PRAC-CHMP-EC
Key dates and outcomes
- Procedure start date
- 20/12/2012
- PRAC recommendation date
- 10/01/2013
- EC decision date
- 22/03/2013
- Outcome
- Suspension